Jubilant Ingrevia Ltd Share Price – NSE  / BSE

Chemicals, Small Cap

Net profit of Jubilant Ingrevia rose 2.63% to Rs 59.00 crore in the quarter ended September 2024 as against Rs 57.49 crore during the previous quarter ended September 2023. Sales rose 1.77% to Rs 1029.00 crore in the quarter ended September 2024 as against Rs 1011.10 crore during the previous quarter ended September 2023.

Powered by Capital Market - Live News

Jubilant Ingrevia has appointed Vijay Srivastava as Chief of Operations & Whole-time Director of the Company subject to the approval of shareholders, effective from 01 November 2024 for a period of 5 years.

Powered by Capital Market - Live News

Jubilant Ingrevia will hold a meeting of the Board of Directors of the Company on 22 October 2024.

Powered by Capital Market - Live News

This partnership will focus on the production of an agro intermediate essential for one of the customer’s key agro active products.

Manufactured Agro Intermediate will be exported from India. The overall consideration will pay based on the revenue of around $300 million plus from supplies of the Agro intermediate to the customer, over a period of next few years after commencement of production.

“A synergistic relationship where JASL leverages its manufacturing prowess coupled with customer’s technology knowhow of key Agro intermediates and Agro actives, global distribution network and brand image in the agrarian space”, the firm said.

Jubilant Ingrevia is a global integrated life science products and innovative solutions provider serving, pharmaceutical, nutrition, agrochemical, consumer and industrial customers with its customised products and solutions that are innovative, cost effective and conforming to premium quality standards. The company is engaged in manufacturing and supply of speciality chemicals, nutrition & health solutions and chemical intermediates through five manufacturing facilities in India.

The company reported 15.36% decline in consolidated net profit to Rs 48.74 crore in Q1 FY25 as compared with net profit of Rs 57.59 crore in Q1 FY24. Total revenue from operations stood at Rs 1,024.34 crore in Q1 FY25, down 4.71% from Rs 1,075.02 crore in Q1 FY24.

The scrip hit 52-week high at Rs 836.95 in intraday today.

Powered by Capital Market - Live News